Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
M.D. Anderson Cancer Center Pharmacia LifeCell |
---|---|
Information provided by: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT00038012 |
A Pilot Study of Transfusion of rhTPO-Derived Autologous Platelets Cryopreserved with ThromboSol and 2% DMSO in Patients with Gynecologic Malignancy Receiving Carboplatin
Condition | Intervention |
---|---|
Neoplasms, Gynecologic |
Drug: Thrombopoietin, Carboplatin Procedure: Platelet-pheresis |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | A Pilot Study of Transfusion of rhTPO-Derived Autologous Platelets Cryopreserved With Thrombosol and 2% DMSO in Patients With Gynecologic Malignancy Receiving Carboplatin |
Ages Eligible for Study: | 15 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA:
EXCLUSION CRITERIA:
Study ID Numbers: | GYN97-310 |
Study First Received: | May 24, 2002 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00038012 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Dose-intensified carboplatin autologous cryopreserved platelets thrombopoietin Gynecologic malignancy |
Genital Neoplasms, Female Urogenital Neoplasms Carboplatin |
Neoplasms Neoplasms by Site Antineoplastic Agents Therapeutic Uses |
Genital Neoplasms, Female Urogenital Neoplasms Carboplatin Pharmacologic Actions |